Evolent Health, Inc (EVH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Evolent Health, Inc (EVH) Healthcare & Pipeline Overview

Evolent Health, Inc. delivers clinical and administrative solutions for payers and providers, focusing on value-based care. The company's integrated platform, Identifi, and specialty care management services in oncology and cardiology, position it within the evolving healthcare landscape, emphasizing cost-effective patient-centric care.

What Is the Investment Thesis for EVH?

Evolent Health operates in the growing healthcare information services market, driven by the shift towards value-based care. The company's Identifi platform and clinical solutions offer potential for revenue growth by improving care coordination and cost management. With a market capitalization of $469M, Evolent Health's future performance will depend on its ability to scale its services and manage its negative profit margin of -26.3%. Key catalysts include expanding its client base and further penetration into the oncology and cardiology markets. Potential risks include competition and the ability to maintain technological advantage.

Based on FMP financials and quantitative analysis

EVH Key Highlights

Market Cap of $469M reflects its current valuation in the healthcare information services market.

• Negative Profit Margin of -26.3% indicates challenges in achieving profitability, requiring focus on cost management and revenue growth.
• Gross Margin of 12.9% suggests potential for improvement through operational efficiencies and pricing strategies.
• Beta of 0.37 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
• No Dividend Yield reflects a focus on reinvesting earnings for growth rather than returning capital to shareholders.

Who Are EVH's Competitors?

EVH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are EVH's Key Strengths?

Integrated administrative and clinical platform.

• Proprietary Identifi technology.
• Expertise in value-based care models.
• Strong relationships with payers and providers.

What Are EVH's Weaknesses?

Negative profit margin.

• Reliance on U.S. healthcare system.
• Limited geographic diversification.
• Competitive market.

What Could Drive EVH Stock Higher?

Expansion of the Identifi platform to integrate new data analytics and care coordination features.

• Potential new partnerships with large healthcare providers in Q3 2026.
• Increasing adoption of value-based care models driving demand for Evolent Health's services.
• Launch of new specialty care management programs in Q4 2026.

What Are the Key Risks for EVH?

Financial-distress signal — its Altman Z-Score of -0.39 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-99.2%) — the business is not currently generating profit on shareholder capital.
• Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
• Intense competition from larger, more established healthcare companies.
• Changes in healthcare regulations and policies could impact Evolent Health's business model.
• Economic downturn affecting healthcare spending and payer budgets.
• Technological advancements by competitors could erode Evolent Health's competitive advantage.

What Are the Growth Opportunities for EVH?

• Expansion of Identifi Platform: Evolent Health can expand the capabilities and market reach of its Identifi platform. The global healthcare analytics market is projected to reach $67.9 billion by 2029, growing at a CAGR of 24.7% from 2022. By enhancing Identifi's data analytics and care coordination features, Evolent Health can attract more payers and providers seeking to improve population health management and reduce costs. This expansion can be achieved through strategic partnerships and investments in technology development.
• Penetration of Oncology and Cardiology Markets: Evolent Health's Clinical Solutions segment has significant growth potential in the oncology and cardiology markets. The global oncology market is expected to reach $286.6 billion by 2031, growing at a CAGR of 12.4% from 2021. Similarly, the cardiology market is projected to reach $39.5 billion by 2028. By offering specialized care management services tailored to these high-cost areas, Evolent Health can capture a larger share of the market and improve patient outcomes.
• Strategic Partnerships with Payers and Providers: Forming strategic partnerships with payers and providers can drive growth for Evolent Health. By collaborating with healthcare organizations, Evolent Health can integrate its solutions into their existing workflows and gain access to a broader patient population. These partnerships can also lead to the development of new services and solutions that address specific needs within the healthcare industry. The timeline for establishing these partnerships can vary, but typically takes 6-12 months to finalize.
• Adoption of Value-Based Care Models: The increasing adoption of value-based care models presents a significant growth opportunity for Evolent Health. As healthcare organizations shift away from fee-for-service models, they require solutions that can help them manage risk, improve care coordination, and reduce costs. Evolent Health's integrated administrative and clinical platform is well-positioned to support this transition. The adoption of value-based care is expected to continue growing, driven by government initiatives and the need to improve healthcare affordability.
• Geographic Expansion: Evolent Health can expand its geographic reach by targeting new markets and regions. The company currently operates in the United States, but there is potential to expand internationally. By entering new markets, Evolent Health can diversify its revenue streams and reduce its reliance on the U.S. healthcare system. The timeline for geographic expansion can vary depending on the market, but typically takes 1-2 years to establish a presence and build relationships with local payers and providers.

What Are EVH's Competitive Advantages?

• Proprietary Technology: The Identifi platform provides a unique data aggregation and care management solution.
• Integrated Services: Offers a comprehensive suite of administrative and clinical services.
• Specialty Care Expertise: Focuses on high-cost areas like oncology and cardiology.
• Established Relationships: Strong partnerships with payers and providers.

What Does EVH Do?

Founded in 2011 and headquartered in Arlington, Virginia, Evolent Health, Inc. operates as a healthcare company that provides clinical and administrative solutions to payers and providers through its subsidiary, Evolent Health LLC. The company is structured into two primary segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services segment offers an integrated administrative and clinical platform designed for health plan administration and population health management. This includes financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management. A key component of this segment is Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, aiming to improve population health performance and deliver patient-centric, cost-effective care. The Clinical Solutions segment provides specialty care management services, supporting stakeholders in oncology and cardiology as they transition from fee-for-service to value-based care models. These services are designed to improve the total cost of care, regardless of the stakeholder's maturity stage or specific market dynamics.

What Products and Services Does EVH Offer?

• Provides clinical and administrative solutions to healthcare payers and providers.
• Offers an integrated platform for health plan administration and population health management.
• Delivers financial and administrative management services, including risk management and analytics.
• Utilizes Identifi, a proprietary technology system for data aggregation and care workflow management.
• Offers specialty care management services in oncology and cardiology.
• Supports the transition from fee-for-service to value-based care models.
• Focuses on improving patient outcomes and reducing the total cost of care.

How Does EVH Make Money?

• Generates revenue through contracts with payers and providers for its administrative and clinical solutions.
• Offers subscription-based access to its Identifi platform.
• Provides fee-based services for specialty care management in oncology and cardiology.
• Revenue is derived from health plan services, risk management, analytics, and reporting.

What Industry Does EVH Operate In?

Evolent Health operates within the healthcare information services industry, which is experiencing growth driven by the increasing adoption of value-based care models. The industry is characterized by a shift towards data-driven healthcare solutions and the need for improved care coordination. Evolent Health competes with other healthcare IT companies and consulting firms that offer similar services. The market is competitive, with companies vying to provide comprehensive solutions that address the challenges of managing population health and controlling healthcare costs. The industry is expected to continue growing as healthcare providers and payers seek to improve efficiency and outcomes.

Who Are EVH's Key Customers?

• Healthcare payers, including health plans and insurance companies.
• Healthcare providers, such as hospitals, physician groups, and integrated delivery networks.
• Specialty care delivery stakeholders in oncology and cardiology.

Over the past six months, Evolent Health, Inc insiders filed 17 SEC Form 4 transactions — 4 sales and 13 purchases. On net that is roughly 1.1M shares acquired (about $430K) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: Evolent Health, Inc

Revenue for Evolent Health, Inc came in at $652.5M during Q2 FY2026, a 31.5% improvement versus the preceding quarter. The company recorded a net loss of $28.4M, with diluted EPS of $-0.25. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Healthcare company. Across the four most recent quarters, EVH averaged $-1.11 in diluted EPS.

EVH Valuation & Market Position

With a $469M market cap, Evolent Health, Inc sits in the small-cap segment of the market. Analyst price targets span from $7.00 to $7.00, with a consensus of $7.00. At the current price of $4.17, that implies approximately 68% upside potential. Relative to its peer group, EVH's quantitative score of 20/100 is below the peer average of 63/100.

Return on equity for Evolent Health, Inc stands at -99.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -25.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 3.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.24 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -91.8%, the inverse of the P/E and a quick read on earnings relative to price.

Evolent Health, Inc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.39 places it in the distress zone, a signal of elevated financial risk.

Evolent Health, Inc has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 12.6% below estimates on average.

Company Profile

Evolent Health, Inc operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Arlington, US. The company is led by CEO Seth Barrie Blackley. EVH has traded publicly since 2015.

EVH Financials

EVH Latest News

EVH Analyst Consensus

EVH MoonshotScore

What Investors Ask About Evolent Health, Inc (EVH) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources